Brief: Haemonetics Corp Reaffirms Fiscal 2025 EPS Outlook
07/11/2024 12:32
Nov 7 (Reuters) - Haemonetics Corp HAE.N :
* HAEMONETICS CORP - REAFFIRMS FISCAL 2025 EPS OUTLOOK
* HAEMONETICS CORP - Q2 FISCAL 2025 ADJUSTED EPS $1.12
* HAEMONETICS CORP - Q2 FISCAL 2025 REVENUE $346 MILLION
Further company coverage: HAE.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Haemonetics
See all newsBrief: Haemonetics Announces FDA Approval Of Perqseal® Elite Vascular Closure System
Haemonetics says FDA clears vascular closure device
US STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Haemonetics surges as CSL plans to move all US plasma centers to its devices